Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimising CAR-T Cell Patient Outcomes by Individualized Supportive Care and Exercise Interventions
DRKS00034842Phase 2Recruiting
- Sponsor
- LMU Klinikum
- Start
- Aug 2024
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Gene Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ISIKOK-19 in hematopoietic malignancies, sponsored by LMU Klinikum. Started Aug 2024; status: recruiting.
02
Drugs
ISIKOK-19
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on DRKS00034842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00034842.